Loading clinical trials...

TERMINATEDPhase 2/3NCT00682656

Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis

The adequate treatment of the American tegumentary leishmaniasis is crucial since the disease, differently from the caused by the Old World species, is painful and not self-healing and may lead to the...

Lead sponsor: Ana Rabello•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

NCT06798402 · Cutaneous Leishmaniasis

RECRUITINGPhase 3

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

NCT04268524 · Old World Cutaneous Leishmaniasis

COMPLETED

Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease

NCT06692985 · Cutaneous Leishmaniasis

COMPLETEDPhase 2

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

NCT01300975 · Leishmaniasis, Cutaneous Leishmaniasis

COMPLETEDPhase 2/3

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

NCT03829917 · Cutaneous Leishmaniasis, American

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 17, 2014Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2/PHASE3

Enrollment48

Start dateJun 2008

Last updatedOct 17, 2014

Condition

Cutaneous Leishmaniasis

Locations shown

Núcleo de Medicina Tropical University of Brasília - Health Center Corte de Pedras

Presidente Tancredo Neves, Estado de Bahia

Centro de Pesquisas René Rachou - Fiocruz

Belo Horizonte, Minas Gerais

University Estadual de Montes Claros

Montes Claros, Minas Gerais

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 17, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions